Page last updated: 2024-09-04

n-(gamma-maleimidobutyryloxy)succinimide and Leukemia, Lymphocytic, Chronic, B-Cell

n-(gamma-maleimidobutyryloxy)succinimide has been researched along with Leukemia, Lymphocytic, Chronic, B-Cell in 1 studies

*Leukemia, Lymphocytic, Chronic, B-Cell: A chronic leukemia characterized by abnormal B-lymphocytes and often generalized lymphadenopathy. In patients presenting predominately with blood and bone marrow involvement it is called chronic lymphocytic leukemia (CLL); in those predominately with enlarged lymph nodes it is called small lymphocytic lymphoma. These terms represent spectrums of the same disease. [MeSH]

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Baloun, J; Doubek, M; Horák, D; Plichta, Z; Pospíšilová, Š; Proks, V; Studená, R; Svozilová, H1

Other Studies

1 other study(ies) available for n-(gamma-maleimidobutyryloxy)succinimide and Leukemia, Lymphocytic, Chronic, B-Cell

ArticleYear
RGDS-Modified Superporous Poly(2-Hydroxyethyl Methacrylate)-Based Scaffolds as 3D In Vitro Leukemia Model.
    International journal of molecular sciences, 2021, Feb-27, Volume: 22, Issue:5

    Topics: Cell Culture Techniques; Cell Line, Tumor; Humans; Hydrogels; Leukemia, Lymphocytic, Chronic, B-Cell; Mesenchymal Stem Cells; Oligopeptides; Porosity; Succinimides; Tissue Scaffolds

2021